Frontline Treatment Strategies in Non–Clear Cell RCC: Emerging Data and Trials

Panelists discuss the treatment landscape in non–clear cell RCC, highlighting how treatment approaches differ from clear cell RCC, relevant data from frontline settings, and emerging trials of note in this subset of patients.

EP: 1.Understanding Advanced RCC: Epidemiology, Presentation, and Risk Stratification

EP: 2.James’ Journey with Clear Cell RCC: Diagnosis, Early Challenges, and His Treatment Journey

EP: 3.The Role of the Multidisciplinary Care Team in RCC

EP: 4.Exploring Standards of Care and Treatment Goals in Advanced Clear Cell RCC

EP: 5.Selecting the Right RCC Treatment Plan: Shared Decision-Making and Expert Advice

EP: 6.Key Clinical Trial Data and Insights in Advanced Clear Cell RCC

EP: 7.Proactively Managing Toxicities in RCC IO/TKI Combinations: Insights and Recommendations

Now Viewing

EP: 8.Frontline Treatment Strategies in Non–Clear Cell RCC: Emerging Data and Trials

EP: 9.Enhancing Supportive Care and Quality of Life for RCC Patients

EP: 10.Improving the RCC Patient Journey and Future Therapeutic Directions

Video content above is prompted by the following:

• How do treatment approaches differ in non–clear cell RCC? Please briefly highlight relevant data in the frontline setting and any emerging trials of note.

Recent Videos